| 期 |
栏目 |
标题 |
文件 |
| 卷 32, 编号 11 (2021) |
Articles |
Analysis of the efficacy of Osteomed and Osteomed Forte in the treatment of osteoporotic fractures of various localization |
|
| 卷 33, 编号 6 (2022) |
From Practice |
Comprehensive prevention of age-related and cardiovascular diseases: the use of the Russian natural remedy BioDihydroquercetin of the Baikal Legend trade mark |
|
| 卷 33, 编号 8 (2022) |
From Practice |
Chaga birch mushroom: anti-inflammatory, antioxidant, immunomodulatory, antiviral effects, the possibility of using the Russian drug BioChaga in patients with novel coronavirus infection (COVID-19) |
|
| 卷 33, 编号 9 (2022) |
Pharmacology |
The drug Cardioton: composition, pharmacological properties, the possibilities of preventing cardiovascular diseases |
|
| 卷 33, 编号 11 (2022) |
From Practice |
Selenium, selenium-containing drugs, antioxidant action: possibility of application in clinical practice |
|
| 卷 33, 编号 12 (2022) |
From Practice |
Application of hawthorn blood-red and rosehip fruits in the drug Kardioton in the prevention of various diseases |
|
| 卷 34, 编号 1 (2023) |
Pharmacology |
The use of Osteomed, Osteomed Forte, and Osteo-Vit D3 in the prevention and therapy of fractures in patients with osteoporosis |
|
| 卷 34, 编号 2 (2023) |
From Practice |
The use of selenium-containing drugs in the prevention and treatment of complications in patients with COVID-19 |
|
| 卷 34, 编号 5 (2023) |
Pharmacology |
Cardiotone: pharmacological properties of hawthorn blood-red, possibility of use in patients with cardiovascular diseases |
|
| 卷 34, 编号 6 (2023) |
Pharmacology |
Flavonoids quercetin, dihydroquercetin (taxifolin): antioxidant and anti-ischemic effects, possibility of application in cardiology |
|
| 卷 34, 编号 7 (2023) |
From Practice |
Erectile dysfunction in men with cardiovascular disease: the possibility of prevention with Eromax |
|
| 卷 34, 编号 8 (2023) |
From Practice |
Possibility of using Femoklim in menopause women with cardiovascular pathologies |
|
| 卷 34, 编号 11 (2023) |
From Practice |
Anemia: epidemiology, clinical-pathogenetic associations, risk of development, selenium deficiency, prevention, selenium-containing drugs |
|
